OrsoBio

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$67M

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.